| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |